Qiagen
company
QIA Frankfurt SE · home listing
QGEN NYSE
ISIN NL0000240000 SEC CIK 1015820 LEI 54930036WK3GMCN17Z57
Follow Qiagen
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.1B | $437M |
| FY24 | $2B | $59.8M |
| FY23 | $2B | $484.8M |
| FY22 | $2.1B | $575.7M |
| FY21 | $2.3B | $537.1M |
| FY20 | $1.9B | $73.6M |
| FY19 | $1.5B | −$69.8M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 61.9% | 22.4% | 20.9% |
| FY24 | 48.6% | 5.9% | 3% |
| FY23 | 62.5% | 21% | 24.7% |
| FY22 | 64.2% | 24.9% | 26.9% |
| FY21 | 64.2% | 28.2% | 23.9% |
| FY20 | 65.6% | 20.5% | 3.9% |
| FY19 | 65.4% | −3.3% | −4.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $615.2M |
| FY24 | $639.8M |
| FY23 | $451.4M |
| FY22 | $694.8M |
| FY21 | $537.4M |
| FY20 | $412.4M |
| FY19 | $306.4M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $54.2M | - |
| FY24 | - | - |
| FY23 | - | - |
| FY22 | - | $0 |
| FY21 | - | $100M |
| FY20 | - | $64M |
| FY19 | - | $74.5M |
- Qiagen
- Healthcare median
Show the numbers
| Year | Qiagen | Healthcare median |
|---|---|---|
| FY25 | 20.9% | −30.6% |
| FY24 | 3% | −47% |
| FY23 | 24.7% | −58% |
| FY22 | 26.9% | −80.4% |
| FY21 | 23.9% | −71.9% |
| FY20 | 3.9% | −62.2% |
| FY19 | −4.6% | −46.3% |